Riskpilot← Back to searchSign inGet full accessAVICENNA AS
ASActiveOrg 997985931Øverlands Gate 19B, 7500 StjørdalGeneral medical practice activities · NACE 8621Est. 20121 employees
Revenue 2024
NOK 2,6M
+133% vs 2023
EBITDA margin
90.6%
+240% vs 2023
Equity ratio
80.6%
Financial strength
Net profit 2024
NOK 2,2M
+80% vs 2023
| Revenue | NOK 2,6M | +133% |
| EBITDA | NOK 2,4M | +240% |
| Net profit | NOK 2,2M | +80% |
| Total assets | NOK 5,5M | -12% |
| Equity | NOK 4,4M | +18% |
| Employees | 1 | — |
Legal name
AVICENNA AS
Org number
997985931
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
16. februar 2012
Share capital
NOK 60 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive legevirksomhet og konsulentvirksomhet innenfor rådgivning, undervisning, helse, samt investeringsvirksomhet i verdipapirer og eiendom.
Address
Øverlands Gate 19B, 7500 Stjørdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 495 | 2 443 | 1 869 | 1 116 | 2 606 |
| Staff expenses | −20 | −17 | −22 | −11 | −0 |
| EBITDA | 291 | 2 006 | 1 245 | 694 | 2 360 |
| Depreciation & amort. | −287 | −287 | −100 | −7 | −7 |
| EBIT | 4 | 1 719 | 1 145 | 687 | 2 354 |
| Net financials | 658 | 14 867 | −4 159 | 524 | −170 |
| Profit before tax | 662 | 16 587 | −3 014 | 1 211 | 2 184 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 662 | 16 587 | −3 014 | 1 211 | 2 184 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 22 550 | 27 953 | 22 537 | 6 185 | 5 466 |
| Equity | 2 537 | 12 123 | 6 509 | 3 721 | 4 404 |
| Long-term debt | 789 | 619 | 447 | 306 | 101 |
| Short-term debt | 19 224 | 15 210 | 15 580 | 2 158 | 961 |
| Total debt | 20 014 | 15 830 | 16 028 | 2 464 | 1 062 |
EBITDA margin
90.6%
This company
15.8%
Market median
+473% vs market
20202024
Equity ratio
80.6%
This company
38.2%
Market median
+111% vs market
20202024
Return on equity
49.6%
This company
18.4%
Market median
+170% vs market
20202024
Net profit margin
83.8%
This company
8.1%
Market median
+935% vs market
20202024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BS Chief Executive Officer | Chief Executive Officer | 2012 |
JS Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AVICENNA AS 
Saga Bht AsBoard members of AVICENNA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarne Storset | Chief Executive Officer | 0 companies |
| Judy Stomsvik Storset | Deputy Member | 0 companies |
| Soodabe Sarkheil | Deputy Chairman | 0 companies |